Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors
- 122 Downloads
Hodgkin lymphoma (HL) survivors experience high risks of second cancers and cardiovascular disease, but no studies have considered whether the occurrence of these and other medical conditions differ by sociodemographic factors in adolescent and young adult (AYA) survivors.
Data for 5,085 patients aged 15–39 when diagnosed with HL during 1996–2012 and surviving ≥ 2 years were obtained from the California Cancer Registry and linked to hospitalization data. We examined the impact of race/ethnicity, neighborhood socioeconomic status (SES), and health insurance on the occurrence of medical conditions (≥ 2 years after diagnosis) and the impact of medical conditions on survival using multivariable Cox proportional hazards regression.
Twenty-six percent of AYAs experienced at least one medical condition and 15% had ≥ 2 medical conditions after treatment for HL. In multivariable analyses, Black HL survivors had a higher likelihood (vs. non-Hispanic Whites) of endocrine [hazard ratio (HR) = 1.37, 95% confidence interval (CI) 1.05–1.78] and circulatory system diseases (HR = 1.58, CI 1.17–2.14); Hispanics had a higher likelihood of endocrine diseases [HR = 1.24 (1.04–1.48)]. AYAs with public or no insurance (vs. private/military) had higher likelihood of circulatory system diseases, respiratory system diseases, chronic kidney disease/renal failure, liver disease, and endocrine diseases. AYAs residing in low SES neighborhoods (vs. high) had higher likelihood of respiratory system and endocrine diseases. AYAs with these medical conditions or second cancers had an over twofold increased risk of death.
Strategies to improve health care utilization for surveillance and secondary prevention among AYA HL survivors at increased risk of medical conditions may improve outcomes.
KeywordsHodgkin lymphoma Insurance Adolescent Young adult Race/ethnicity Second cancer Circulatory system Respiratory system Endocrine system
This work was supported by the Rich and Weissman Family Lymphoma and Survivorship Fund St. Baldrick’s Research Grant. In addition, Dr. Flowers’ effort was supported by the National Cancer Institute U01CA195568 and K24CA208132, and Dr. Wun’s effort also supported by the National Center for Advancing Translational Sciences TR000002. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section103885; the National Cancer Institute’s Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention’s National Program of Cancer Registries, under agreement U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author(s) and endorsement by the State of California, Department of Public Health the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
- 1.Nass SJ, Beaupin LK, Demark-Wahnefried W, Fasciano K, Ganz PA, Hayes-Lattin B, Hudson MM, Nevidjon B, Oeffinger KC, Rechis R, Richardson LC, Seibel NL, Smith AW (2015) Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop. Oncologist 20(2):186–195. https://doi.org/10.1634/theoncologist.2014-0265 CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosery CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2015) SEER Cancer Statistics Review, 1975–2012. http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015 edn. National Cancer Institute, Bethesda, MD
- 6.Keegan TH, DeRouen MC, Parsons HM, Clarke CA, Goldberg D, Flowers CR, Glaser SL (2016) Impact of treatment and insurance on socioeconomic disparities in survival after adolescent and young adult Hodgkin lymphoma: a population-based study. Cancer Epidemiol Biomarkers Prev 25(2):264–273. https://doi.org/10.1158/1055-9965.EPI-15-0756 CrossRefPubMedPubMedCentralGoogle Scholar
- 7.van Nimwegen FA, Schaapveld M, Janus CP, Krol AD, Petersen EJ, Raemaekers JM, Kok WE, Aleman BM, van Leeuwen FE (2015) Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern Med 175(6):1007–1017. https://doi.org/10.1001/jamainternmed.2015.1180 CrossRefPubMedGoogle Scholar
- 11.Castellino SM, Geiger AM, Mertens AC, Leisenring WM, Tooze JA, Goodman P, Stovall M, Robison LL, Hudson MM (2011) Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood 117(6):1806–1816. https://doi.org/10.1182/blood-2010-04-278796 CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, Roesink J, Raemaekers JM, de Boer JP, Zijlstra JM, van Imhoff GW, Petersen EJ, Poortmans PM, Beijert M, Lybeert ML, Mulder I, Visser O, Louwman MW, Krul IM, Lugtenburg PJ, van Leeuwen FE (2015) Second cancer risk up to 40 years after treatment for Hodgkin’s lymphoma. N Engl J Med 373(26):2499–2511. https://doi.org/10.1056/NEJMoa1505949 CrossRefPubMedGoogle Scholar
- 14.Bhuller KS, Zhang Y, Li D, Sehn LH, Goddard K, McBride ML, Rogers PC (2016) Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer. Br J Haematol 172(5):757–768. https://doi.org/10.1111/bjh.13903 CrossRefPubMedGoogle Scholar
- 16.Fritz F, Percy C, Jack A, Shanmugaratnan K, Sobin L, Parkin DM, Whelan S (eds) (2000) International classification of diseases for oncology, 3 edn. World Health Organization, GenevaGoogle Scholar
- 18.Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M, Pacelli R (2012) Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 82(5):1802–1808. https://doi.org/10.1016/j.ijrobp.2010.09.054 CrossRefPubMedGoogle Scholar
- 24.Lin G, So Y, Johnston G (2012) Analyzing survival data with competing risks using SAS® Software. Proceedings of the SAS® Global Forum 2012 Conference. SAS Institute Inc, Cary, NCGoogle Scholar
- 26.Rugbjerg K, Maraldo M, Aznar MC, Cutter DJ, Darby SC, Specht L, Olsen JH (2017) Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: a nationwide cohort study. Int J Cancer 140(10):2232–2245. https://doi.org/10.1002/ijc.30655 CrossRefPubMedPubMedCentralGoogle Scholar
- 29.Keegan TH, Tao L, DeRouen MC, Wu XC, Prasad P, Lynch CF, Shnorhavorian M, Zebrack BJ, Chu R, Harlan LC, Smith AW, Parsons HM, Group AHSC. (2014) Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers? J Cancer Surviv 8(2):282–292. https://doi.org/10.1007/s11764-013-0332-4 CrossRefPubMedPubMedCentralGoogle Scholar
- 33.Parsons HM, Schmidt S, Harlan LC, Kent EE, Lynch CF, Smith AW, Keegan TH, Collaborative AH (2014) Young and uninsured: insurance patterns of recently diagnosed adolescent and young adult cancer survivors in the AYA HOPE study. Cancer 120(15):2352–2360. https://doi.org/10.1002/cncr.28685 CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Centers for Disease Control and Prevention (2013) Coronary heart disease and stroke deaths—United States, 2009. MMWR 62(Suppl 3):157–160Google Scholar
- 38.Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, Sosa JA, Sumner AE, Anton B (2012) Health disparities in endocrine disorders: biological, clinical, and nonclinical factors—an endocrine society scientific statement. J Clin Endocrinol Metab 97(9):E1579–E1639. https://doi.org/10.1210/jc.2012-2043 CrossRefGoogle Scholar